Business Standard

Friday, December 20, 2024 | 03:17 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Drug sales stuck at pre-pandemic level, price rise shapes market growth

Respiratory medicines doing well as people recover from long-term effects of Covid-19

drugs, pharma, prices, drug prices, medicines, health
Premium

While volumes remaining stagnant are a concern, the value growth has been positive for the IPM

Sohini Das Mumbai

Listen to This Article

Drug sale volumes are almost stuck at pre-pandemic levels but price growth has improved value, data from market research agency Pharmarack AWACS showed.

The Indian pharmaceutical market’s (IPM) volumes in April 2023 grew by 0.21 percent when compared to April 2019. Key therapy areas like cardiac, anti-diabetic and vitamins recorded negative volume or consumption growth, while respiratory, anti-infectives, and pain and analgesics had positive growth from April 2019 to April this year. (see chart).

Covid-19 primarily affects the respiratory system; individuals who have recovered from the virus may experience long-term respiratory symptoms like cough or shortness of breath. For people

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in